Background: The clear evidence of cardiovascular benefits in cardiovascular outcome trials of sodium-glucose cotransporter 2 inhibitors (SGLT2i) in type 2 diabetes might suggest an effect on atherosclerotic plaque vulnerability and/or thrombosis, in which myeloid angiogenic cells (MAC) and platelets (PLT) are implicated. We tested the effects of SGLT2i on inflammation and oxidant stress in a model of stearic acid (SA)-induced lipotoxicity in MAC and on PLT activation. The possible involvement of the Na+/H+ exchanger (NHE) was also explored. Method: MAC and PLT were isolated from peripheral blood of healthy subjects and incubated with/without SGLT2i [empagliflozin (EMPA) and dapagliflozin (DAPA) 1-100 μM] to assess their effects on SA (100 μ...
Diabetes is a growing epidemic worldwide characterized by an elevated concentration of blood glucose...
Sodium glucose cotransporter 2 (SGLT2) inhibitors are a class of medication with broad cardiovascula...
Abnormality in glucose homeostasis due to hyperglycemia or insulin resistance is the hallmark of typ...
Objective: We evaluated sodium-glucose co-transporter2 (SGLT2) expression and the effect of SGLT2 in...
This editorial refers to ‘Delayed ischemic contracture onset by empagliflozin associates with NHE1 i...
Indiana University-Purdue University Indianapolis (IUPUI)Recent clinical outcome studies demonstrate...
BACKGROUND: The inflammatory response occurring in acute myocardial infarction (AMI) has been propos...
Background. Diabetes is a complex disease which currently affects 425 million people worldwide and t...
Sodium-glucose cotransporter-2 inhibitors (SGLT2i) are effective, well-tolerated, and safe glucose-l...
Sodium glucose cotransporter 2 inhibitors (SGLT2) have been increasingly pursued as a promising targ...
Atherosclerosis is a progressive inflammatory disease leading to mortality and morbidity in the civi...
Sodium glucose co-transporter 2 inhibitors (SGLT-2is) improve cardiovascular outcomes in both diabet...
Diabetes is a global epidemic and a leading cause of death with more than 422 million patients world...
Background: Despite the effectiveness of primary coronary angioplasty in reducing myocardial infarct...
Aim: Recent studies have demonstrated that selective sodium–glucose cotransporter 2 inhibitors (SGLT...
Diabetes is a growing epidemic worldwide characterized by an elevated concentration of blood glucose...
Sodium glucose cotransporter 2 (SGLT2) inhibitors are a class of medication with broad cardiovascula...
Abnormality in glucose homeostasis due to hyperglycemia or insulin resistance is the hallmark of typ...
Objective: We evaluated sodium-glucose co-transporter2 (SGLT2) expression and the effect of SGLT2 in...
This editorial refers to ‘Delayed ischemic contracture onset by empagliflozin associates with NHE1 i...
Indiana University-Purdue University Indianapolis (IUPUI)Recent clinical outcome studies demonstrate...
BACKGROUND: The inflammatory response occurring in acute myocardial infarction (AMI) has been propos...
Background. Diabetes is a complex disease which currently affects 425 million people worldwide and t...
Sodium-glucose cotransporter-2 inhibitors (SGLT2i) are effective, well-tolerated, and safe glucose-l...
Sodium glucose cotransporter 2 inhibitors (SGLT2) have been increasingly pursued as a promising targ...
Atherosclerosis is a progressive inflammatory disease leading to mortality and morbidity in the civi...
Sodium glucose co-transporter 2 inhibitors (SGLT-2is) improve cardiovascular outcomes in both diabet...
Diabetes is a global epidemic and a leading cause of death with more than 422 million patients world...
Background: Despite the effectiveness of primary coronary angioplasty in reducing myocardial infarct...
Aim: Recent studies have demonstrated that selective sodium–glucose cotransporter 2 inhibitors (SGLT...
Diabetes is a growing epidemic worldwide characterized by an elevated concentration of blood glucose...
Sodium glucose cotransporter 2 (SGLT2) inhibitors are a class of medication with broad cardiovascula...
Abnormality in glucose homeostasis due to hyperglycemia or insulin resistance is the hallmark of typ...